AOD9604 vs HGH Fragment 176-191: Research Comparison
A Side-By-Side Research Comparison Of AOD9604 And HGH Fragment 176-191 - two HGH-fragment analogs studied for fat-metabolism research. This Reference Compares Mechanism, Evidence Tier, Molecular Identity, And Pharmacokinetics For Qualified Researchers. For In Vitro Laboratory Research Use Only. Not Medical Advice Or Dosing Guidance.
Side-By-Side Comparison
| AOD9604 | HGH Fragment 176-191 | |
|---|---|---|
| Category | Weight Loss & Metabolism | Muscle Growth & Performance |
| Compound Class | Modified C-terminal growth-hormone fragment (hGH 177-191) | Synthetic fragment of HGH C-terminus (residues 176-191) |
| Evidence Tier | Research Compound | Research Compound |
| Molecular Target | Lipolysis via beta-3 adrenergic and lipase pathways; no GH receptor binding; no IGF-1 elevation | Beta-3 adrenergic receptors; stimulates lipolysis without GH receptor binding; no IGF-1 elevation |
| Molecular Weight | 1815.1 Da | 1817.1 Da |
| Amino Acid Sequence | GH 176-191 with N-terminal Tyr (16 aa) | 16-aa C-terminal lipolytic fragment of human growth hormone (residues 176-191) |
| CAS Number | 221231-10-3 | 66004-57-7 |
| Half-Life | ~3 minutes | ~3 minutes |
| Studied For | Obesity / fat-metabolism research, Lipolysis / fat burning, Adipose tissue reduction, Body fat reduction without IGF-1 elevation | Lipolysis / fat loss, Adipose reduction, Visceral fat reduction, Body composition improvement |
About AOD9604
A growth-hormone fragment for fat loss that failed its key human trial; banned in sport.
Read The Full AOD9604 MonographAbout HGH Fragment 176-191
A growth-hormone fragment marketed for fat loss; human efficacy is unproven and it is banned in sport.
Read The Full HGH Fragment 176-191 MonographKey Differences
- AOD9604 is categorized under Weight Loss & Metabolism, while HGH Fragment 176-191 falls under Muscle Growth & Performance.
- Primary molecular target differs: AOD9604 acts on Lipolysis via beta-3 adrenergic and lipase pathways; no GH receptor binding; no IGF-1 elevation; HGH Fragment 176-191 acts on Beta-3 adrenergic receptors; stimulates lipolysis without GH receptor binding; no IGF-1 elevation.
Continue Researching
AOD9604 · HGH Fragment 176-191 · Compare Tool · Research Library
This Comparison Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption, Diagnosis, Or Treatment. See The Full Research Disclaimer.